Nervous System Disorders Stocks List

Recent Signals

Date Stock Signal Type
2021-02-25 ACAD 20 DMA Resistance Bearish
2021-02-25 ACAD Fell Below 200 DMA Bearish
2021-02-25 ACAD Stochastic Reached Oversold Weakness
2021-02-25 ACOR Lower Bollinger Band Walk Weakness
2021-02-25 APTX 20 DMA Resistance Bearish
2021-02-25 APTX Fell Below 50 DMA Bearish
2021-02-25 APTX Fell Below 200 DMA Bearish
2021-02-25 AXSM Death Cross Bearish
2021-02-25 AXSM 20 DMA Resistance Bearish
2021-02-25 AXSM 180 Bearish Setup Bearish Swing Setup
2021-02-25 BEAM Fell Below 50 DMA Bearish
2021-02-25 DRRX Stochastic Reached Oversold Weakness
2021-02-25 DRRX Fell Below 50 DMA Bearish
2021-02-25 DRRX NR7 Range Contraction
2021-02-25 ENDP Non-ADX 1,2,3,4 Bullish Bullish Swing Setup
2021-02-25 ENDP 1,2,3 Pullback Bullish Bullish Swing Setup
2021-02-25 ENDP MACD Bearish Signal Line Cross Bearish
2021-02-25 HUGE 50 DMA Support Bullish
2021-02-25 IRWD Lower Bollinger Band Walk Weakness
2021-02-25 PASG Lower Bollinger Band Walk Weakness
2021-02-25 PRAX 20 DMA Resistance Bearish
2021-02-25 PRAX Wide Range Bar Range Expansion
2021-02-25 PRAX Lower Bollinger Band Walk Weakness
2021-02-25 PRTC Fell Below 20 DMA Bearish
2021-02-25 SAGE Bollinger Band Squeeze Range Contraction
2021-02-25 SAGE Fell Below 50 DMA Bearish
2021-02-25 SAGE 20 DMA Support Bullish
2021-02-25 SAVA 1,2,3 Pullback Bullish Bullish Swing Setup
2021-02-25 SAVA Non-ADX 1,2,3,4 Bullish Bullish Swing Setup
2021-02-25 TRVN 200 DMA Support Bullish
2021-02-25 VNDA New 52 Week High Strength
2021-02-25 ZGNX Bearish Engulfing Bearish
2021-02-25 ZGNX Fell Below 200 DMA Bearish
2021-02-25 ZGNX Slingshot Bullish Bullish Swing Setup

Recent News for Nervous System Disorders Stocks

Date Stock Title
Feb 26 SAGE Premarket analyst action - healthcare
Feb 26 SAGE Sage Therapeutics, Inc. (NASDAQ:SAGE) Analysts Just Cut Their EPS Forecasts Substantially
Feb 26 ZGNX Zogenix, Inc. (ZGNX) CEO Stephen Farr on Q4 2020 Results - Earnings Call Transcript
Feb 25 ENDP Endo posts Q4 beat on Sterile Injectables strength
Feb 25 ENDP Endo EPS beats by $0.27, beats on revenue
Feb 25 ENDP Endo Reports Fourth-Quarter And Full-Year 2020 Financial Results And Introduces 2021 Financial Guidance
Feb 25 ZGNX Zogenix EPS beats by $2.26, beats on revenue
Feb 25 ZGNX Zogenix Provides Corporate Update and Reports Fourth Quarter and Full-Year 2020 Financial Results
Feb 25 SAGE Sage Therapeutics: Steady Recovery After Biogen Deal
Feb 25 ACAD ROCE Insights For ACADIA Pharmaceuticals
Feb 25 PRTC PureTech Announces Publication of Glyph™ Platform Preclinical Proof-of-Concept Study in Journal of Controlled Release
Feb 25 SAGE Sage Posts Surprise Quarterly Profit As Sales Surge; Shares Pop 6%
Feb 25 ACOR Acorda Fourth Quarter/Year End 2020 Update: Webcast/Conference Call Scheduled for March 4, 2021
Feb 25 KRTX Karuna Therapeutics EPS beats by $0.03
Feb 25 KRTX Karuna Therapeutics Reports Fourth Quarter and Year End 2020 Financial Results and Provides General Business Update
Feb 25 ZGNX Earnings Scheduled For February 25, 2021
Feb 25 ACAD ACADIA Pharmaceuticals Inc. 2020 Q4 - Results - Earnings Call Presentation
Feb 25 PRTC PureTech Founded Entity Karuna Therapeutics Announces New England Journal of Medicine Publication of Data from EMERGENT-1 Phase 2 Trial Evaluating KarXT in Schizophrenia
Feb 25 ACAD ACADIA Pharmaceuticals Inc. (ACAD) CEO Steve Davis on Q4 2020 Results - Earnings Call Transcript
Feb 24 ENDP Endo Q4 2020 Earnings Preview